Table 1.
Baseline Characteristics of OBOT Patients on Buprenorphine between 2002 and 2014 at Boston Medical Center Primary Care (N= 1308)
| Demographics | N (%) or median (IQR) |
|---|---|
| Age (years) (N=1308) | 37 (28, 46) |
| Male (N = 1292) | 791 (61.2%) |
| Race/Ethnicity (N=1270) | |
| White | 860 (67.7%) |
| Black | 190 (15.0%) |
| Hispanic | 202 (15.9%) |
| Other | 18 (1.4%) |
| Employment status (N=1240) | |
| Unemployed | 800 (64.5%) |
| Full or part time employment | 255 (20.6%) |
| Disabled or retired | 147 (11.8%) |
| Student | 38 (3.1%) |
| Education (N=1045) | |
| Less than high school | 374 (35.8%) |
| Completed high school or GED | 318 (30.4%) |
| Some college or vocational Completed | 128 (12.2%) |
| College | 225 (21.5%) |
| Buprenorphine dose (mg) (N=1308) | 16 (12, 16) |
| Smoking (N=868) | 687 (82.0%) |
| Psychiatric Diagnosis | |
| Any diagnosis | 821 (62.8%) |
| Depression | 627 (47.9%) |
| Anxiety or Panic | 394 (30.1%) |
| Bipolar or Mania | 165 (12.6%) |
| Schizophrenia or psychosis | 63 (5.0%) |
| ADHD | 65 (5.0%) |
| Days to Disengagement /Censoring | 316 (108,1021) |
| Disenrolled within the first 6 Months | 453 (34.6%) |
| Prescribed a Psychoactive Medication | 562 (43.0%) |
| Prescribed an Emerging Risk Psychoactive Medication | 223 (17%) |
Legend:
IQR – Interquartile range
Prescribed a Psychoactive Medication- On enrollment, prescribed at least one of the following: selective serotonin re-uptake inhibitor (SSRI), bupropion, trazodone, mirtazapine, tricyclic antidepressant, non-benzodiazepine anxiolytic, serotonin–norepinephrine reuptake inhibitor (SNRI), antipsychotic, benzodiazepine, gabapentin, clonidine or promethazine
Prescribed an Emerging Risk Psychoactive Medication – On enrollment, prescribed gabapentin, clonidine or promethazine